Cystic Fibrosis-Reference-Cited by-同舟云学术

Cystic Fibrosis

Published:2023-11-02 Issue:18 Volume:389 Page:1693-1707
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Grasemann Hartmut¹,Ratjen Felix¹^ORCID

Affiliation:

1. From the Division of Respiratory Medicine, Department of Pediatrics, and Translational Medicine, Research Institute, Hospital for Sick Children, University of Toronto, Toronto.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMra2216474

Reference92 articles.

1. Cystic fibrosis

2. Origins of Cystic Fibrosis Lung Disease

3. Contemporary cystic fibrosis incidence rates in Canada and the United States

4. Cystic Fibrosis Foundation patient registry 2021 annual data report. Bethesda, MD: Cystic Fibrosis Foundation, 2022 (https://www.cff.org/sites/default/files/2021-11/Patient-Registry-Annual-Data-Report.pdf).

5. Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 Years with Cystic Fibrosis and at Least One F508del Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor;The Journal of Pediatrics;2024-11

2. Impact of triple transmembrane regulator therapy on glucose metabolism in cystic fibrosis related diabetes during clinical practice;Diabetes Research and Clinical Practice;2024-10

3. Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis;Clinical Microbiology Reviews;2024-09-12

4. Treatment of Acute and Long-COVID, Diabetes, Myocardial Infarction, and Alzheimer’s Disease: The Potential Role of a Novel Nano-Compound—The Transdermal Glutathione–Cyclodextrin Complex;Antioxidants;2024-09-12

5. Dysregulation of the Arachidonic Acid Pathway in Cystic Fibrosis: Implications for Chronic Inflammation and Disease Progression;Pharmaceuticals;2024-09-09